Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. Adults: National health and nutrition examination surveys 2003-2006

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 5, 2012, Pages 363-372

  Maki, Kevin C ^a   Fulgoni, Victor L ^b   Keast, Debra R ^c   Rains, Tia M ^a   Park, Keigan M ^d   Rubin, Martyn R ^d  

^a Biofortis Clinical Research   (United States)

^b Nutrition Impact LLC   (United States)

^c Food and Nutrition Database Research Inc   (United States)

^d Dairy Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; POVERTY; PREVALENCE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; EATING; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; NUTRITIONAL STATUS; PREVALENCE; UNITED STATES; VITAMIN D; YOUNG ADULT;

EID: 84872831376     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0020     Document Type: Article

References (44)

1. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004;80:1706S-1709S.
2. Giovannucci E. Can vitamin D reduce total mortality? Arch Intern Med 2007;167:1709-1710.
3. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
4. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008;168:1174-1180.
5. Maki KC, Rubin MR, Wong LG, et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009;3:289-296.
6. Hyppönen E, Boucher BJ, Berry DJ, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: A cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008;57:298-305.
7. Smotkin-Tangorra M, Purushothaman R, Gupta A, et al. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007;20:817-823.
8. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007;26:573-580.
9. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and metaanalysis. Maturitas 2010;65:225-236.
10. National Center for Health Statistics. National Health and Nutrition Examination Survey, 1999-current. Survey operation manuals, brochures, consent documents, May 2010. Available at www.cdc.gov/nchs/nhanes/nhanes2005-2006/ nhanes05-06.htm/. Accessed June 23, 2012.
11. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109: 433-438.
12. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. National health statistics reports; no 13. Hyattsville, MD: National Center for Health Statistics; 2009.
13. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-2497.
14. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
15. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: The Cremona Study. Diabetes Care 2011;34:210-215.
16. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009;32:2297-2299.
17. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30:771-777.
18. National Center for Health Statistics. Revised Analytical Note for NHANES 2000-2006 and NHANES III (1988-1994) 25-Hydroxyvitamin D Analysis (revised November 2010), May 2010. Available at http://www.cdc.gov/nchs/data/nhanes/ nhanes3/VitaminD-analyticnote.pdf/. Accessed June 23, 2012.
19. U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, et al. What We Eat in America, NHANES 2005-2006. Beltsville, MD, Hyattsville, MD. Available at www.ars.usda .gov/foodsurvey/. Accessed June 23, 2012.
20. National Center for Health Statistics. National Health and Nutrition Examination Survey, 1999-current. Survey questionnaires, examination components, and laboratory components, May 2010. Available at www.cdc.gov/nchs/nhanes/ nhanes2005-2006/nhanes05-06.htm/. Accessed June 23, 2012.
21. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825.
22. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-1230.
23. Reis JP, von Mihlen D, Miller ER III. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endrocrinol 2008;159:41-48.
24. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press; 2011.
25. Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-1637.
26. Michaëlsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: A community-based prospective cohort study. Am J Clin Nutr 2010;92:841-848.
27. Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139:329-334.
28. National Cholesterol Education Program Expert Panel, Third Report. Detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel III). NIH Publication 02-5215. Available at www.nhlbi.nih.gov/ guidelines/cholesterol/atp3-rpt.htm/. Accessed June 23, 2012.
29. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
30. Carbone LD, Rosenberg EW, Tolley EA, et al. 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. Metabolism 2008;57:741-748.
31. Jorde R, Sneve M, Hutchinson M, et al. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a populationbased study and during 12 months in an intervention study. Am J Epidemiol 2010;171:903-908.
32. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham heart study. Diabetes 2010;59:242-248.
33. Earthman CP, Beckman LM, Masodkar K, et al. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: Considerations and implications. Int J Obes 2012;36:387-396.
34. Rosenstreich SJ, Rich C, Volwiler W. Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest 1971;50:679-687.
35. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72: 690-693.
36. Jiang H, Xiong DH, Guo YF, et al. Association analysis of vitamin D-binding protein gene polymorphisms with variations of obesity-related traits in Caucasian nuclear families. Int J Obes 2007;31:1319-1324.
37. Winters SJ, Chennubhatia R,Wang C, et al. Influence of obesity on vitamin D-binding protein and 25-hydroxyvitamin D levels in African American and white women. Metabolism 2009;58: 438-442.
38. Harris SS, Pittas AG, Palermo NJ. A randomized, placebocontrolled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab, 2012; doi:10.1111/j.1463-1326.2012. 01605.x.
39. Mitri J, Dawson-Hughes B, Hu FB, et al. Effects of vitamin D and calcium supplementation on pancreatic b cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011;94:486-494.
40. Zemel MB. Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr 2004; 79:907S-912S.
41. Pereira MA, Jacobs DR Jr, Van Horn L, et al. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: The CARDIA Study. JAMA 2002;287:2081-2089.
42. Ruidavets JB, Bongard V, Simon C, et al. Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. J Hypertens 2006;24:671-681.
43. Tremblay A, Gilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009;28:91S-102S.
44. Johnson RK, Goran MI, Poehlman ET. Correlates of overand underreporting of energy intake in healthy older men and women. Am J Clin Nutr 1994;59:1286-1290.